Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
primary ciliary dyskinesia 32
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
08/08/2024
Evidence/Notes:

RSPH3 was first described as a primary ciliary dyskinesia (PCD)-causing gene in 2015 (Jeanson et al. 2015, PMID: 26073779). The specific disease entity, primary ciliary dyskinesia 32 (MONDO:0014657, OMIM:616481), is one of at least 45 different primary ciliary dyskinesias distinguished by a single monogenic cause. Some of the common clinical phenotypes are: neonatal respiratory distress syndrome, bronchiectasis, male/female infertility, chronic rhinosinusitis, otitis media, reduced nasal nitric oxide, and reduced or absent ciliary motility.

RSPH3 encodes a protein of the radial spoke of the ciliary axoneme. This curation includes six variants (3 nonsense, 1 frameshift, 1 missense and 1 canonical splice site) that have been reported in 6 unrelated probands in 2 publications (PMIDs: 26073779 and 32124190). Overall, the pattern of variants observed in the probands indicated that the mechanism of pathogenicity appears to be loss of RSPH3 function. However, it is important to note that missense variants contribute to the gene-disease relationship through mechanisms that have not yet been well-studied.

This gene-disease relationship is supported by multiple kinds of experimental evidence ranging from gene expression and biochemical studies to non-human model organisms (PMID: 23715323, PMID: 16607017, PMID: 28915070). High levels of expression of RSPH3 are found in human tissues associated with motile cilia (testis, lungs, and brain/hypothalamus, PMID: 23715323). An RSPH3 ortholog knockout in Trypanosoma brucei recapitulated phenotypes displayed by patients carrying pathogenic variants in RSPH3, including reduced ciliary beat frequency (PMID: 16607017). RSPH3 localizes to radial spoke heads (PMID: 28915070), matching the RSPH9 protein previously shown to be associated with PCD 12 (19200523). A zebrafish model lacking the orthologous gene encoding lrrc23, a component of the radial spoke neck, showed otolith defects (an ear problem which indicates an underlying problem with ciliary movement, PMID: 29475374). Lastly, a naturally occurring Chlamydomonas mutant “pf14” lacks the RSPH3 ortholog and shows abnormal flagellar morphology and movement as well as central pair defects when examined by electron microscopy (PMID: 24283352).

In conclusion, RSPH3 is definitively associated with autosomal recessive primary ciliary dyskinesia 32. This classification has been clearly demonstrated and confirmed through both experimental and genetic evidence and has been upheld over time without the emergence of contradictory evidence. This classification was approved by the ClinGen Motile Ciliopathy GCEP on August 8th, 2024 (SOP Version 10).

PubMed IDs:
16607017 23715323 24283352 26073779 28915070 29475374 32124190
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.